Nanomedicine targeted anti-inflammatory therapy to deal with the ‘crux’ of rheumatoid arthritis

References

• Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373(9664):659–672. doi:10.1016/S0140-6736(09)60008-8.Epub 2009 Jan 20. PMID: 19157532.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219. PMID: 22150039. doi:10.1056/NEJMra1004965.
   PubMed Web of Science ®Google Scholar
• Almutairi KB, Nossent JC, Preen DB, et al. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol. 2021;48(5):669–676. Epub 2020 Oct 15.PMID:33060323. doi:10.3899/jrheum.200367.
   PubMed Web of Science ®Google Scholar
• Moon KW. AB1016 The change of prevalence of rheumatoid arthritis and osteoarthritis in Korea between 2011 and 2014. Ann Rheum Dis. 2016;75:1249.
   Google Scholar
• Ishihara T, Kubota T, Choi T, et al. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J Pharmacol Exp Ther. 2009;329(2):412–417. Epub 2009 Feb 25. PMID: 19244548. doi:10.1124/jpet.108.150276.
   PubMed Web of Science ®Google Scholar
• Markides H, Kehoe O, Morris RH, et al. Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells–a rheumatoid arthritis mouse model. Stem Cell Res Ther. 2013;4(5):126. PMID: 24406201; PMCID: PMC3854718. doi:10.1186/scrt337.
   PubMedGoogle Scholar
• Li ZG. A new look at rheumatology in China–opportunities and challenges. Nat Rev Rheumatol. 2015;11(5):313–317. Epub 2015 Jan 20. PMID: 25599919. doi:10.1038/nrrheum.2014.218.
   PubMed Web of Science ®Google Scholar
• O’Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004; 350(25):2591–2602. PMID: 15201416. doi:10.1056/NEJMra040226.
   PubMed Web of Science ®Google Scholar
• Yang M, Feng X, Ding J, et al. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 2017;252:108–124. Epub 2017 Feb 28. PMID: 28257989. doi:10.1016/j.jconrel.2017.02.032.
   PubMed Web of Science ®Google Scholar
• Khan GJ, Gao Y, Gu M, et al. TGF-β1 causes EMT by regulating N-acetyl glucosaminyl transferases via downregulation of non muscle myosin II-a through JNK/P38/PI3K pathway in lung cancer. Curr Cancer Drug Targets. 2018;18(2):209–219. PMID: 28782471. doi:10.2174/1568009617666170807120304.
   PubMed Web of Science ®Google Scholar
• Klimak M, Nims RJ, Pferdehirt L, et al. Immunoengineering the next generation of arthritis therapies. Acta Biomater. 2021;133:74–86. Epub 2021 Apr 3. PMID: 33823324; PMCID: PMC8941669. doi:10.1016/j.actbio.2021.03.062.
   PubMed Web of Science ®Google Scholar
• Wang Q, Qin X, Fang J, et al. Nanomedicines for the treatment of rheumatoid arthritis: state of art and potential therapeutic strategies. Acta Pharm Sin B. 2021;11(5):1158–1174. Epub 2021 Mar 12. PMID: 34094826; PMCID: PMC8144894. doi:10.1016/j.apsb.2021.03.013.
   PubMed Web of Science ®Google Scholar
• Khan GJ, Sun L, Abbas M, et al. In-vitro pre-treatment of cancer cells with TGF-β1: a novel approach of tail vein lung cancer metastasis mouse model for anti-metastatic studies. Curr Mol Pharmacol. 2019;12(4):249–260. PMID: 30848226. doi:10.2174/1874467212666190306165703.
   PubMed Web of Science ®Google Scholar
• Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S2. Epub 2013 Jul 24. PMID: 24267197; PMCID: PMC3891482. doi:10.1186/ar4174.
   PubMedGoogle Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4(1):18001. Feb 8 PMID: 29417936. doi:10.1038/nrdp.2018.1.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 2017; 5(8):1407–1420. PMID: 28631779. doi:10.1039/c7bm00254h.
   PubMed Web of Science ®Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196. PMID: 28228278; PMCID: PMC5385708. doi:10.1016/j.immuni.2017.02.006.
   PubMed Web of Science ®Google Scholar
• Culemann S, Grüneboom A, Nicolás-Ávila JÁ, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572(7771):670–675. Epub 2019 Aug 7. PMID: 31391580; PMCID: PMC6805223. doi:10.1038/s41586-019-1471-1.
   PubMed Web of Science ®Google Scholar
• Shen Q, Zhang X, Qi J, et al. Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis. Int J Pharm. 2020;576:119001. Epub 2019 Dec 29. PMID: 31893540. doi:10.1016/j.ijpharm.2019.119001.
   PubMedGoogle Scholar
• Jia M, Deng C, Luo J, et al. A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. Int J Pharm. 2018;540(1-2):57–64. Epub 2018 Feb 2. PMID: 29408684. doi:10.1016/j.ijpharm.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Hu L, Luo X, Zhou S, et al. Neutrophil-mediated delivery of dexamethasone palmitate-loaded liposomes decorated with a sialic acid conjugate for rheumatoid arthritis treatment. Pharm Res. 2019;36(7):97. PMID: 31076925. doi:10.1007/s11095-019-2609-4.
   PubMed Web of Science ®Google Scholar
• Verma A, Jain A, Tiwari A, et al. Folate conjugated double liposomes bearing prednisolone and methotrexate for targeting rheumatoid arthritis. Pharm Res. 2019;36(8):123. PMID: 31218557. doi:10.1007/s11095-019-2653-0.
   PubMed Web of Science ®Google Scholar
• Arias JL, López-Viota M, López-Viota J, et al. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Int J Pharm. 2009;382(1-2):270–276. Epub 2009 Aug 25. PMID: 19712736. doi:10.1016/j.ijpharm.2009.08.019.
   PubMedGoogle Scholar
• Pham CT. Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(6):607–619. Epub 2011 Aug 11. PMID: 21837725; PMCID: PMC3800699. doi:10.1002/wnan.157.
   PubMed Web of Science ®Google Scholar
• Thomas TP, Goonewardena SN, Majoros IJ, et al. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum. 2011;63(9):2671–2680. PMID: 21618461; PMCID: PMC3168725. doi:10.1002/art.30459.
   PubMed Web of Science ®Google Scholar
• Horisawa E, Kubota K, Tuboi I, et al. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res. 2002;19(2):132–139. PMID: 11883639. doi:10.1023/a:1014260513728.
   PubMed Web of Science ®Google Scholar
• Fiehn C, Müller-Ladner U, Gay S, et al. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Rheumatology (Oxford). 2004;43(9):1097–1105. Epub 2004 Jun 15. PMID: 15199219. doi:10.1093/rheumatology/keh254.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. Epub 2016 Nov 11. PMID: 27834398; PMCID: PMC5575742. doi:10.1038/nrc.2016.108.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zou J, Chen Z, et al. Current research trends of nanomedicines. Acta Pharm Sin B. 2023;13(11):4391–4416. Epub 2023 May 20. PMID: 37969727; PMCID: PMC10638504. doi:10.1016/j.apsb.2023.05.018.
   PubMed Web of Science ®Google Scholar
• Higaki M, Ishihara T, Izumo N, et al. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis. 2005;64(8):1132–1136. Epub 2005 Feb 4. PMID: 15695536; PMCID: PMC1755606. doi:10.1136/ard.2004.030759.
   PubMed Web of Science ®Google Scholar
• Hayder M, Poupot M, Baron M, et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med. 2011;3(81):81ra35. PMID: 21543721. doi:10.1126/scitranslmed.3002212.
   PubMed Web of Science ®Google Scholar
• Chandrasekar D, Sistla R, Ahmad FJ, et al. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J Biomed Mater Res A. 2007;82(1):92–103. PMID: 17269145. doi:10.1002/jbm.a.31122.
   PubMedGoogle Scholar
• Chamberland DL, Agarwal A, Kotov N, et al. Photoacoustic tomography of joints aided by an etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study. Nanotechnology. 2008;19(9):095101. Epub 2008 Feb 11. PMID: 21817663. doi:10.1088/0957-4484/19/9/095101.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee K, Kim IK, et al. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials. 2008;29(35):4709–4718. Epub 2008 Sep 25. PMID: 18817971. doi:10.1016/j.biomaterials.2008.08.038.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim HJ, Ha YJ, et al. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. ACS Nano. 2013;7(1):50–57. Epub 2012 Dec 7. PMID: 23194301. doi:10.1021/nn301215q.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee MY, Bhang SH, et al. Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. ACS Nano. 2014;8(5):4790–4798. Epub 2014 Apr 14. PMID: 24730974. doi:10.1021/nn500685h.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Q, Zhou X, et al. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm. 2008;352(1–2):273–279. Epub 2007 Oct 22. PMID: 18054182. doi:10.1016/j.ijpharm.2007.10.014.
   PubMedGoogle Scholar
• Xue M, Jiang ZZ, Wu T, et al. Anti-inflammatory effects and hepatotoxicity of tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats. Phytomedicine. 2012;19(11):998–1006. Epub 2012 Aug 10. PMID: 22884304. doi:10.1016/j.phymed.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Nagai N, Ito Y. Effect of solid nanoparticle of indomethacin on therapy for rheumatoid arthritis in adjuvant-induced arthritis rat. Biol Pharm Bull. 2014;37(7):1109–1118. PMID: 24989003. doi:10.1248/bpb.b13-00917.
   PubMed Web of Science ®Google Scholar
• An L, Li Z, Shi L, et al. Inflammation-Targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-κB and Notch1 pathways. Nano Lett. 2020;20(10):7728–7736. Epub 2020 Sep 30. PMID: 32965124. doi:10.1021/acs.nanolett.0c03279.
   PubMed Web of Science ®Google Scholar
• Pandey PK, Maheshwari R, Raval N, et al. Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis. J Colloid Interface Sci. 2019;544:61–77. Epub 2019 Feb 22. PMID: 30825801. doi:10.1016/j.jcis.2019.02.073.
   PubMed Web of Science ®Google Scholar
• Gorzkiewicz M, Janaszewska A, Ficker M, et al. Pyrrolidone-modified PAMAM dendrimers enhance anti-inflammatory potential of indomethacin in vitro. Colloids Surf B Biointerfaces. 2019;181:959–962. Epub 2019 Jun 25. PMID: 31382346. doi:10.1016/j.colsurfb.2019.06.056.
   PubMed Web of Science ®Google Scholar
• Qi R, Majoros I, Misra AC, et al. Folate receptor-targeted Dendrimer-Methotrexate conjugate for inflammatory arthritis. J Biomed Nanotechnol. 2015;11(8):1431–1441. PMID: 26295143. doi:10.1166/jbn.2015.2077.
   PubMed Web of Science ®Google Scholar
• Kofoed Andersen C, Khatri S, Hansen J, et al. Carbon nanotubes-potent carriers for targeted drug delivery in rheumatoid arthritis. Pharmaceutics. 2021;13(4):453. PMID: 33801590; PMCID: PMC8066293. doi:10.3390/pharmaceutics13040453.
   PubMed Web of Science ®Google Scholar
• Lee YK, Kim SW, Park JY, et al. Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential. Int J Nanomed. 2017;12:5761–5779. PMID: 28848352; PMCID: PMC5557625. doi:10.2147/IJN.S142122.
   PubMed Web of Science ®Google Scholar
• Kayat J, Mehra NK, Gajbhiye V, et al. Drug targeting to arthritic region via folic acid appended surface-engineered multi-walled carbon nanotubes. J Drug Target. 2016;24(4):318–327. Epub 2015 Aug 18. PMID: 26289435. doi:10.3109/1061186X.2015.1077846.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhong Z, Wang Y, et al. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. J Nanobiotechnology. 2020;18(1):115. PMID: 32819405; PMCID: PMC7441703. doi:10.1186/s12951-020-00675-6.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xu K, Min J, et al. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis. J Appl Biomater Funct Mater. 2020;18:2280800020962629. PMID: 33155513. doi:10.1177/2280800020962629.
   Web of Science ®Google Scholar
• Ni R, Song G, Fu X, et al. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway. Biomaterials. 2020;232:119730. Epub 2019 Dec 31. PMID: 31918224. doi:10.1016/j.biomaterials.2019.119730.
   PubMed Web of Science ®Google Scholar
• Li J, Chen L, Xu X, et al. Targeted combination of antioxidative and anti-inflammatory therapy of rheumatoid arthritis using multifunctional dendrimer-entrapped gold nanoparticles as a platform. Small. 2020;16(49):e2005661. Epub 2020 Nov 17. PMID: 33205596. doi:10.1002/smll.202005661.
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo L, Wang Z, et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials. 2021;264:120390. Epub 2020 Sep 19. PMID: 32980634. doi:10.1016/j.biomaterials.2020.120390.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhao M, Yu C, et al. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomed. 2017;12:6735–6746. PMID: 28932117; PMCID: PMC5600269. doi:10.2147/IJN.S140992.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Dai F, Deng H, et al. A rheumatoid arthritis magnetic resonance imaging contrast agent based on folic acid conjugated PEG-b-PAA@SPION. J Mater Chem B. 2014;2(19):2938–2946. Epub 2014 Apr 9. PMID: 32261488. doi:10.1039/c4tb00085d.
   PubMed Web of Science ®Google Scholar
• Lu KY, Lin PY, Chuang EY, et al. H2O2-depleting and O2-generating selenium nanoparticles for fluorescence imaging and photodynamic treatment of proinflammatory-activated macrophages. ACS Appl Mater Interfaces. 2017;9(6):5158–5172. Epub 2017 Feb 1. PMID: 28120612. doi:10.1021/acsami.6b15515.
   PubMed Web of Science ®Google Scholar
• Li X, Yu C, Meng X, et al. Study of double-targeting nanoparticles loaded with MCL-1 siRNA and dexamethasone for adjuvant-induced arthritis therapy. Eur J Pharm Biopharm. 2020;154:136–143. Sep Epub 2020 Jul 15. PMID: 32681961. doi:10.1016/j.ejpb.2020.07.009.
   PubMed Web of Science ®Google Scholar
• Zheng C, Wu A, Zhai X, et al. The cellular immunotherapy of integrated photothermal anti-oxidation Pd-Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis. Acta Pharm Sin B. 2021;11(7):1993–2003. Epub 2021 Mar 4. PMID: 34386333; PMCID: PMC8343190. doi:10.1016/j.apsb.2021.02.021.
   PubMed Web of Science ®Google Scholar
• Yu C, Li X, Hou Y, et al. Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats. Molecules. 2019;24(1):146. PMID: 30609724; PMCID: PMC6337373. doi:10.3390/molecules24010146.
   PubMed Web of Science ®Google Scholar
• Zewail M, El-Deeb NM, Mousa MR, et al. Hyaluronic acid coated teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis. Int J Pharm. 2022;623:121939. Epub 2022 Jun 18. PMID: 35724825. doi:10.1016/j.ijpharm.2022.121939.
   PubMedGoogle Scholar
• Pandey S, Rai N, Mahtab A, et al. Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis. Int J Biol Macromol. 2021;171:502–513. Epub 2021 Jan 7. PMID: 33422513. doi:10.1016/j.ijbiomac.2020.12.204.
   PubMed Web of Science ®Google Scholar
• Gorantla S, Puppala ER, Naidu VGM, et al. Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies. Int J Biol Macromol. 2023;224:207–222. Epub 2022 Oct 20. PMID: 36273548. doi:10.1016/j.ijbiomac.2022.10.117.
   PubMed Web of Science ®Google Scholar
• Zhou M, Hou J, Zhong Z, et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv. 2018;25(1):716–722. PMID: 29516758; PMCID: PMC6058688. doi:10.1080/10717544.2018.1447050.
   PubMed Web of Science ®Google Scholar
• Li C, Liu R, Song Y, et al. Hyaluronic acid hydrogels hybridized with Au-triptolide nanoparticles for intraarticular targeted multi-therapy of rheumatoid arthritis. Front Pharmacol. 2022;13:849101. PMID: 35712709; PMCID: PMC9197263. doi:10.3389/fphar.2022.849101.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhu T, Chen J, et al. PLGA/PCADK composite microspheres containing hyaluronic acid-chitosan siRNA nanoparticles: a rational design for rheumatoid arthritis therapy. Int J Pharm. 2021;596:120204. Epub 2021 Jan 23. PMID: 33493604. doi:10.1016/j.ijpharm.2021.120204.
   PubMedGoogle Scholar
• Shin JM, Kim SH, Thambi T, et al. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis. Chem Commun (Camb). 2014;50(57):7632–7635. PMID: 24893961. doi:10.1039/c4cc02595d.
   PubMed Web of Science ®Google Scholar
• Hu S, Lin Y, Tong C, et al. A pH-Driven indomethacin-loaded nanomedicine for effective rheumatoid arthritis therapy by combining with photothermal therapy. J Drug Target. 2022;30(7):737–752. Epub 2022 Mar 28. PMID: 35282742. doi:10.1080/1061186X.2022.2053539.
   PubMed Web of Science ®Google Scholar
• Heo R, Park JS, Jang HJ, et al. Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. J Control Release. 2014;192:295–300. Epub 2014 Aug 7. PMID: 25109660. doi:10.1016/j.jconrel.2014.07.057.
   PubMed Web of Science ®Google Scholar
• Saadat E, Shakor N, Gholami M, et al. Hyaluronic acid based micelle for articular delivery of triamcinolone, preparation, in vitro and in vivo evaluation. Int J Pharm. 2015;489(1–2):218–225. Epub 2015 May 5. PMID: 25956051. doi:10.1016/j.ijpharm.2015.05.001.
   PubMedGoogle Scholar
• Yang L, Sha Y, Wei Y, et al. Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy. Biomater Sci. 2023;11(6):2211–2220. Epub ahead of print. PMID: 36748266. doi:10.1039/d2bm02072f.
   PubMed Web of Science ®Google Scholar
• Fang H, Sha Y, Yang L, et al. Macrophage-targeted hydroxychloroquine nanotherapeutics for rheumatoid arthritis therapy. ACS Appl Mater Interfaces. 2022;14(7):8824–8837. Epub 2022 Feb 14. PMID: 35156814. doi:10.1021/acsami.1c23429.
   PubMed Web of Science ®Google Scholar
• Yu C, Liu H, Guo C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-a receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29(1):454–465. PMID: 35119317; PMCID: PMC8855847. doi:10.1080/10717544.2022.2032482.
   PubMed Web of Science ®Google Scholar
• You DG, Lim GT, Kwon S, et al. Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci Adv. 2021;7(23):eabe0083. PMID: 34078596; PMCID: PMC8172131. doi:10.1126/sciadv.abe0083.
   PubMed Web of Science ®Google Scholar
• Gong T, Tan T, Zhang P, et al. Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. Biomaterials. 2020;258:120296. Epub 2020 Aug 4. PMID: 32781326. doi:10.1016/j.biomaterials.2020.120296.
   PubMed Web of Science ®Google Scholar
• Li P, Yang X, Yang Y, et al. Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice. J Control Release. 2020;319:87–103. Epub 2019 Dec 18. PMID: 31862360. doi:10.1016/j.jconrel.2019.12.025.
   PubMed Web of Science ®Google Scholar
• Shi Y, Xie F, Rao P, et al. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. J Control Release. 2020;320:304–313. Epub 2020 Jan 28. PMID: 32004586. doi:10.1016/j.jconrel.2020.01.054.
   PubMed Web of Science ®Google Scholar
• Lyu J, Wang L, Bai X, et al. Treatment of rheumatoid arthritis by serum albumin nanoparticles coated with mannose to target neutrophils. ACS Appl Mater Interfaces. 2021;13(1):266–276. Epub 2020 Dec 30. PMID: 33379867. doi:10.1021/acsami.0c19468.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li K, Jiao M, et al. Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy. Acta Pharm Sin B. 2023;13(2):787–803. Epub 2022 Aug 23. PMID: 36873164; PMCID: PMC9978920. doi:10.1016/j.apsb.2022.08.012.
   PubMed Web of Science ®Google Scholar
• Lai X, Wang S, Hu M, et al. Dual targeting single arrow: neutrophil-targeted sialic acid-modified nanoplatform for treating comorbid tumors and rheumatoid arthritis. Int J Pharm. 2021;607:121022. Epub 2021 Aug 17. PMID: 34416328. doi:10.1016/j.ijpharm.2021.121022.
   PubMedGoogle Scholar
• Zhang Q, Dehaini D, Zhang Y, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018;13(12):1182–1190. Epub 2018 Sep 3. PMID: 30177807. doi:10.1038/s41565-018-0254-4.
   PubMed Web of Science ®Google Scholar
• Khan GJ, Sun L, Khan S, et al. Versatility of cancer associated fibroblasts: commendable targets for anti-tumor therapy. Curr Drug Targets. 2018;19(13):1573–1588. PMID: 29468965. doi:10.2174/1389450119666180219124439.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Khan GJ, et al. Salicin from alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2-HO-1-ROS pathways. J Agric Food Chem. 2018;66(24):6073–6082. Epub 2018 Jun 11. PMID: 29852739. doi:10.1021/acs.jafc.8b02241.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Chen Y, et al. Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food Funct. 2018;9(4):2070–2079. PMID: 29577119. doi:10.1039/c7fo01748k.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xiao L, Yu C, et al. Enhanced antiarthritic efficacy by nanoparticles of (-)-epigallocatechin gallate-glucosamine-casein. J Agric Food Chem. 2019;67(23):6476–6486. Epub 2019 May 30. PMID: 31117504. doi:10.1021/acs.jafc.9b02075.
   PubMed Web of Science ®Google Scholar
• Liu Y, Rao P, Qian H, et al. Regulatory fibroblast-like synoviocytes cell membrane coated nanoparticles: a novel targeted therapy for rheumatoid arthritis. Adv Sci (Weinh). 2023;10(4):e2204998. Epub 2022 Dec 12. PMID: 36509660; PMCID: PMC9896074. doi:10.1002/advs.202204998.
   PubMedGoogle Scholar
• Lee YK, Choi JK, Kang YJ, et al. Triamcinolone-carbon nanotube conjugation inhibits inflammation of human arthritis synovial fibroblasts. J Mater Chem B. 2016;4(9):1660–1671. Epub 2015 Oct 19. PMID: 32263018. doi:10.1039/c5tb01693b.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhao X, Chen Y, et al. Engineered platelet microparticle-membrane camouflaged nanoparticles for targeting the golgi apparatus of synovial fibroblasts to attenuate rheumatoid arthritis. ACS Nano. 2022;16(11):18430–18447. Epub 2022 Nov 7. PMID: 36342327. doi:10.1021/acsnano.2c06584.
   PubMed Web of Science ®Google Scholar
• Qiu S, Wu X, Li Z, et al. A smart nanoreactor based on an O2-economized dual energy inhibition strategy armed with dual multi-stimuli-responsive "doorkeepers" for enhanced CDT/PTT of rheumatoid arthritis. ACS Nano. 2022;16(10):17062–17079. Epub 2022 Sep 26. PMID: 36153988. doi:10.1021/acsnano.2c07338.
   PubMed Web of Science ®Google Scholar
• You C, Zu J, Liu X, et al. Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation. J Cell Mol Med. 2018;22(4):2449–2457. Epub 2018 Jan 30. PMID: 29383874; PMCID: PMC5867099. doi:10.1111/jcmm.13549.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Z, Li T, et al. Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics. 2019;9(3):708–720. PMID: 30809303; PMCID: PMC6376478. doi:10.7150/thno.30418.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma L, Zhou H, et al. Polypeptide nano-Se targeting inflammation and theranostic rheumatoid arthritis by anti-angiogenic and NO activating AMPKα signaling pathway. J Mater Chem B. 2018;6(21):3497–3514. Epub 2018 May 17. PMID: 32254445. doi:10.1039/c8tb00080h.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhu X, Xu T, et al. Targeted hexagonal Pd nanosheet combination therapy for rheumatoid arthritis via the photothermal controlled release of MTX. J Mater Chem B. 2019;7(1):112–122. Epub 2018 Dec 4. PMID: 32254955. doi:10.1039/c8tb02302f.
   PubMed Web of Science ®Google Scholar
• Xu XL, Li WS, Wang XJ, et al. Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis. Nanoscale. 2018;10(6):2923–2935. PMID: 29369319. doi:10.1039/c7nr08430g.
   PubMed Web of Science ®Google Scholar
• Song Y, Jo S, Chung JY, et al. RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis. J Control Release. 2021;330:1300–1312. Epub 2020 Nov 24. PMID: 33242532. doi:10.1016/j.jconrel.2020.11.041.
   PubMed Web of Science ®Google Scholar